Nikhil Lalwani Sells $401K of ANI Pharmaceuticals Inc (ANIP) — SEC Form 4, Aug 26, 2026
Open-Market Net Sale · SEC Form 4
−$401,220
10b5-1 Plan
Equity position changed by -1.5%
Equity Position
344K sh
349,889 → 344,489
Equity Change
-1.5%
shares held after vs before
Filing Lag
1 business day
within 2-day SEC deadline
Form 4 · Statement of Changes in Beneficial Ownership
Reporting Owner
| Name | Relationship |
|---|---|
| Nikhil Lalwani CIK 0001822629 |
Director
CEO
|
Nikhil Lalwani at ANI Pharmaceuticals Inc
Full insider history
Bought (12 mo)
—
Sold (12 mo)
$5,439,176
More from this insider at ANI Pharmaceuticals Inc
| 2026-10-16 | Sell | -$388,206 | View |
| 2026-09-16 | Sell | -$383,400 | View |
| 2026-05-13 | Sell | -$4,266,350 | View |
| 2026-03-10 | - | — | View |
| 2026-03-02 | Award | — | View |
Non-Derivative Securities Transactions
Footnotes (2)
- F1
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 26, 2026. Show more
- F2
- The shares were sold in multiple trades at prices ranging from $73.58 to $74.61. The price reported above reflects the weighted average sales price. Show more
Related filings at ANI Pharmaceuticals Inc
Institutional Holders
13F holders · Jun 30, 2026
307
institutional managers reporting a position
Largest by reported value
- Black Rock, Inc. $245M
- Soleus Capital Management, L.P. $71.8M
- Vanguard Capital Management Llc $69.4M
5%+ Holders · 13D/G
2 filers
Other insiders at ANI Pharmaceuticals Inc
-
Meredith Cook -$36.8K
-
Stephen P. Carey -$208K
-
Meredith Cook -$35.4K
-
Jeanne Thoma -$71.5K
-
Stephen P. Carey -$207K
GET /v1/forms/4/0001822629-26-000014
API docs
View Original SEC Filing